RE:RE:Post Angiopro and See Bart comment on post SassyWiređź’ˇ ''With the FDA's Breakthrough Designation, companies can secure faster reimbursement across the U.S., offering quicker market access—a game-changer for startups and investors alike.''
2 weeks to 2025 & now the moment we've finally been waiting for FDA V4.0 for our patience and trust with Ventripoint all these years.
2025 years of Ventripoint for children's health and we long for them with Ventripoint.
jopatclo wrote: Sorry bd translation copy.GOOD COPY TRANSLATED =
Post Angiopro and See Bart comment on post SavvyWire
jopatclo wrote: Interesting and remember post (
Bart Hendrikx on
#SavvyWire is the first and only sensor-guided solution designed specifically to optimize TAVR.) Remember post